EAT is up +49.38%% since April’24 pick View All Top Buy Picks

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 110 days ( 7.09 % )
Last Price $0.0930 0 %
High/ Low $0.0930 - $0.0930 0%
Chg 7 Days N/A $0.0930 $0.0930
Chg 30 Days N/A $0.0930 $0.0930
Chg 12 mos -7.00 % $0.100 $0.0930
Trend - 3 mos 22.36 % Width: 74.46 %
Trend - 12 mos -22.98 % Width: 861.21 %
Pred. range - 3 mos $0.0753 - $0.131 -19.06 % - 41.22 %
Pred. range - 12 mos N/A - $0.209 -100.00 % - 124.70 %
Short MA avg 3 mos Buy May 22, 2024 - 26 days
Long MA avg 3 mos Buy May 22, 2024 - 26 days
Short/Long MA avg 3 mos Buy May 23, 2024 - 25 days
Short MA avg 12 mos Buy May 22, 2024 - 26 days
Long MA avg 12 mos Buy May 22, 2024 - 26 days
Short/Long MA avg 12 mos Buy Jun 12, 2024 - 12 days
Pivot Short Sell Jun 26, 2024 - 3 days
Bollinger Sell Nov 30, -1 - N/A days
MACD Sell No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Marizyme, Inc.

Marizyme. Marizyme, Inc., a life science company, engages in the development and commercialization of medical technologies business. It offers DuraGraft, a one-time intraoperative vascular graft treatment for use in vascular and bypass surgeries that maintains endothelial function and structure, and other related properties. The company also develops various products using its Krillase protease-based therapeutic platform for treating complex wounds and bur... MRZM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT